privacy Cannabis Events Patients Treatment 
MMJ Recs
MARCH 2, 2024
In Ohio, accessing medical marijuana involves more than just obtaining a prescription; it requires navigating a complex landscape of dispensaries, regulations, and patient expectations. This guide aims to demystify the process, offering practical advice and insights to help patients make informed decisions.
Cannabis Law Report
JUNE 1, 2021
The initial shipment is designated to be used by the Clinic in a pilot run in preparation for the previously announced study , based out of the United Kingdom, on the safety and efficacy of cannabis and hemp for the treatment of patients suffering from chronic pain. billion, servicing nearly 340,000 active patients.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
CannaMD
SEPTEMBER 15, 2020
Current Florida medical marijuana patient? SHORT ANSWER: In November 2016, the Florida Medical Marijuana Legalization Initiative (known as Amendment 2 ) legalized medical marijuana treatment in Florida. The governor also signed Senate Bill 1700 to protect the privacy of doctors recommending low-THC marijuana and their patients.
Cannabis Law Report
JANUARY 19, 2022
company (TSX:LSPK) and leading virtual provider of evidence-based substance use treatment, announced today its pre-disability TRAiL Hello Premium program will now be offered to Green Shield Canada’s (GSC) plan sponsors as an optional addition to benefit plans. TORONTO–(BUSINESS WIRE)– $LSPK — ALAViDA Health Ltd.
CannaTech
JUNE 30, 2019
Changes to Israeli medical cannabis regulation by the Ministry of Health’s Medical Cannabis Association, locally known as Yakar, have left vulnerable patients with reduced access and increasing cots. Although changes were intended to reduce barriers to patient access, this has not been the case.
CannaTech
JUNE 30, 2019
Israel’s Ministry of Health Medical Cannabis Association (IMCA), locally known as Yakar, recently enacted reforms to medical cannabis regulation. These include changes to reduce barriers to patient access, specific licensing requirements for production, and expanding the number of access points approved of sale.
Cannabis Law Report
OCTOBER 26, 2019
Sponsors must also ensure compliance with the relevant guidelines as to good clinical practice and safety monitoring and reporting, and ensure that the use of personal information complies with the Privacy Act 1988. The choice of which scheme to follow lies first with the sponsor and then with the HREC.
Expert insights. Personalized for you.
52 
Let's personalize your content